Cécile Moluçon‐Chabrot
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 4
- Glioma Diagnosis and Treatment 4
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 7
-
- Lymphoma Diagnosis and Treatment 9
-
- Acute Myeloid Leukemia Research 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Advanced Breast Cancer Therapies 1
-
- Cytomegalovirus and herpesvirus research 2
- Co-authors
- Carole SoussainKhê Hoang‐XuanCaroline HouillierGuido AhleEmmanuelle Nicolas‐VirelizierJacques‐Olivier BayHervé GhesquièresSylvain Choquet
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Cécile Moluçon‐Chabrot
17 papers receiving 199 citations
Peers
Comparison fields: 5 of 34
- Genetics 91
- Neurology 95
- Pathology and Forensic Medicine 95
- Hematology 26
- Reproductive Medicine 15
Countries citing papers authored by Cécile Moluçon‐Chabrot
This map shows the geographic impact of Cécile Moluçon‐Chabrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Moluçon‐Chabrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Moluçon‐Chabrot more than expected).
Fields of papers citing papers by Cécile Moluçon‐Chabrot
This network shows the impact of papers produced by Cécile Moluçon‐Chabrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Moluçon‐Chabrot. The network helps show where Cécile Moluçon‐Chabrot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cécile Moluçon‐Chabrot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 0 | |
| 4 | 2021 | 21 | |
| 5 | 2019 | 9 | |
| 6 | 2017 | 8 | |
| 7 | 2017 | 44 | |
| 8 | 2016 | 2 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 30 | |
| 11 | 2015 | 0 | |
| 12 | 2013 | 8 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 34 | |
| 15 | 2012 | 11 | |
| 16 | 2011 | 3 | |
| 17 | 2009 | 2 | |
| 18 | 2006 | 12 | |
| 19 | Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response. | 2006 | 5 |
About Cécile Moluçon‐Chabrot
Cécile Moluçon‐Chabrot is a scholar working on Genetics, Pathology and Forensic Medicine and Neurology, having authored 19 papers that have together received 201 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Glioma Diagnosis and Treatment (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Advanced Breast Cancer Therapies (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Genetics (91 citations), Neurology (95 citations) and Pathology and Forensic Medicine (95 citations). Cécile Moluçon‐Chabrot has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Carole Soussain, Khê Hoang‐Xuan, Caroline Houillier, Guido Ahle, Emmanuelle Nicolas‐Virelizier, Jacques‐Olivier Bay, Hervé Ghesquières, Sylvain Choquet, Jacques Vargaftig and Jacques Olivier Bay. Their work appears in journals such as Journal of Clinical Oncology, Blood and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.